Re: Characteristics of TRK-130 (Naltalimide), a Novel Opioid Ligand, as a New Therapeutic Agent for Overactive Bladder.

@article{Wein2016ReCO,
  title={Re: Characteristics of TRK-130 (Naltalimide), a Novel Opioid Ligand, as a New Therapeutic Agent for Overactive Bladder.},
  author={A. Wein},
  journal={The Journal of urology},
  year={2016},
  volume={195 1},
  pages={
          223
        }
}
  • A. Wein
  • Published 2016
  • Medicine
  • The Journal of urology
  • available at http://www.ncbi.nlm.nih.gov/pubmed/24928951 Editorial Comment: There are multiple potential mechanisms for stimulating, inhibiting and modulating lower urinary tract storage and emptying. The study of these has greatly enhanced our knowledge of the physiology and pharmacology of lower urinary tract function, including suprasacral influences. Exclusive of the contribution of the study of these compounds to the physiology and pharmacology of micturition, such studies have yielded… CONTINUE READING
    1 Citations